Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Elena Casolati"'
Autor:
Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Marius Roșu, Ciprian Crișan
Publikováno v:
Journal of International Medical Research, Vol 52 (2024)
Objective Recurrent bacterial vaginosis (RBV) after antibiotic treatment has relapse rates of 35% within 3 months and 60% within 12 months. A medical device containing polycarbophil, lauryl glucoside, and glycerides (PLGG) inhibits bacterial growth a
Externí odkaz:
https://doaj.org/article/b186e5383ef74704993a854a4002d8c9
Autor:
Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Federica Sbrocca, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Roșu, Ciprian Doru Crișan
Publikováno v:
JMIR Research Protocols, Vol 12, p e42787 (2023)
BackgroundThe medical literature has reported that recurrent bacterial vaginosis (RBV) has a relapse rate of 35% within 3 months and 60% within 12 months after antibiotic administration. Products that are able to provide a barrier effect against the
Externí odkaz:
https://doaj.org/article/58b82925c4804428a56a1d056caa78bb
Autor:
Angelo Cagnacci, Dionisio Franco Barattini, Elena Casolati, Alberto Pecoroni, Mario Mangrella, Liviu Cristian Patrascu
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 270:239-245
During menopausal transition, women are frequently affected by vulvovaginal atrophy (VVA), due to the decline of estrogen levels. Resulting symptoms are itching, burning, dyspareunia, and vaginal dryness (reported in up to 85%). The aim of this trial
Autor:
Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Federica Sbrocca, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Marius Roșu, Ciprian Crișan
BACKGROUND Medical literature has evidenced in recurrent bacterial vaginosis a relapse rate of 35% within 3 months and 60% within 12 months after antibiotic administration. The products able to create a barrier effect against the biofilm produced by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60b09950ceac5d3eef327b72222cb708
https://doi.org/10.2196/preprints.42787
https://doi.org/10.2196/preprints.42787
Autor:
Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Federica Sbrocca, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Marius Roșu, Ciprian Crișan
Publikováno v:
JMIR Research Protocols.
Autor:
Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Marius Roșu, Ciprian Crișan
Recurrent bacterial vaginosis (RBV) after antibiotic treatments has a relapse rate of 35% within 3 months and 60% within 12 months. Products containing polycarbophil (PLGG), that inhibits bacterial growth and mucoadhesive property, can impair biofilm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bc3f272e1e021c26bbf655a0a16cc49
https://doi.org/10.20944/preprints202209.0131.v1
https://doi.org/10.20944/preprints202209.0131.v1
Autor:
Luca I Ardolino, Filippo Murina, Elena Casolati, Ciprian Crișan, Marius Biriș, Daniela Sîrbu, Dionisio F Barattini
Publikováno v:
Minerva Ginecologica. 72
BACKGROUND The effectiveness of a new vaginal medical device, which contains polycarbophil, 0.04% lauryl glucoside and glycerides (Polybactum®, Effik Italia Spa, Cinisello Balsamo, Milan, Italy), in reducing BV recurrence rate was investigated. METH
Autor:
Isabelle Heard, Lynette Denny, Catherine Moore, Elena Casolati, Caroline Bradbeer, F Lyons, Joanna Adams, Gerry Beattie, David Mesher, Linsey Nelson, Heather Cubie, Alberto Agarossi, Peter Sasieni, Tomasz Niemiec, Henry C Kitchener
Publikováno v:
International journal of cancer. 121(11)
The objectives of this prospective multicentre international cohort study are to describe the characteristics of a cohort of HIV-1 positive women and determine the best management system by comparing cervical pathology according to results of cytolog
Publikováno v:
Medycyna wieku rozwojowego. 7(4 Pt 1)
Among genital malignancies, vulvar cancer and its precursor, Vulvar Intraepithelial Neoplasia (VIN), is less commonly encountered than cervical neoplasia. According to R.W. Jones (2001) vulvar cancer represents about 3-5% of all genital neoplasms and
Autor:
Alberto, Agarossi, Elena, Casolati, Monica, Valieri, Enrico, Ferrazzi, Giada, Maffeis, Daria, Trabattoni, Mario, Clerici
Publikováno v:
Medycyna wieku rozwojowego. 7(4 Pt 1)
Mucosal immunity plays a central role in the control of genital human papilloma virus (HPV) infection. HIV infection is associated with higher risks of HPV-induced neoplasias. Prevalence, incidence and evolution of genital HPV lesions are correlated